These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6970731

  • 1. Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains.
    Adams GE, Ahmed I, Clarke ED, O'Neill P, Parrick J, Stratford IJ, Wallace RG, Wardman P, Watts ME.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Dec; 38(6):613-26. PubMed ID: 6970731
    [Abstract] [Full Text] [Related]

  • 2. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I, Stratford IJ, Jenkins TC.
    Arzneimittelforschung; 1985 Dec; 35(12):1763-8. PubMed ID: 4096727
    [Abstract] [Full Text] [Related]

  • 3. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents.
    Jenkins TC, Stratford IJ, Stephens MA.
    Anticancer Drug Des; 1989 Aug; 4(2):145-60. PubMed ID: 2803463
    [Abstract] [Full Text] [Related]

  • 4. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
    Astor M, Hall EJ, Biaglow JE, Parham JC.
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
    Stratford IJ, Williamson C, Hardy C.
    Br J Cancer; 1981 Jul; 44(1):109-16. PubMed ID: 7259957
    [Abstract] [Full Text] [Related]

  • 6. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
    Zhou L, Nishimoto S.
    Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
    Hay MP, Wilson WR, Moselen JW, Palmer BD, Denny WA.
    J Med Chem; 1994 Feb 04; 37(3):381-91. PubMed ID: 8308864
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio.
    Adams GE, Clarke ED, Gray P, Jacobs RS, Stratford IJ, Wardman P, Watts ME, Parrick J, Wallace RG, Smithen CE.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1979 Feb 04; 35(2):151-60. PubMed ID: 312784
    [Abstract] [Full Text] [Related]

  • 9. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
    Watts ME, Jacobs RS.
    Br J Cancer Suppl; 1978 Jun 04; 3():80-3. PubMed ID: 277262
    [Abstract] [Full Text] [Related]

  • 10. Abnormal radiosensitizing and cytotoxic properties of ortho-substituted nitroimidazoles.
    Stratford IJ, Hoe S, Adams GE, Hardy C, Williamson C.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jan 04; 43(1):31-43. PubMed ID: 6601069
    [Abstract] [Full Text] [Related]

  • 11. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
    Gupta RP, Larroquette CA, Agrawal KC, Grodkowski J, Neta P.
    J Med Chem; 1985 Aug 04; 28(8):987-91. PubMed ID: 4020837
    [Abstract] [Full Text] [Related]

  • 12. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M, Hall EJ.
    Br J Cancer; 1979 May 04; 39(5):510-5. PubMed ID: 486306
    [Abstract] [Full Text] [Related]

  • 13. Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.
    Millar BC, Jinks S, Powles TJ.
    Br J Cancer; 1981 Nov 04; 44(5):733-40. PubMed ID: 7317272
    [Abstract] [Full Text] [Related]

  • 14. Nitroimidazoles, XIV: Synthesis of 4-nitroimidazoles with 1-substituents containing acid, ester or phenol functions, and radiosensitizing efficiency of some of these compounds.
    Suwinski J, Szczepankiewicz W, Widel M.
    Arch Pharm (Weinheim); 1992 Jun 04; 325(6):317-24. PubMed ID: 1444756
    [Abstract] [Full Text] [Related]

  • 15. Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.
    Sakaguchi M, Webb MW, Agrawal KC.
    J Med Chem; 1982 Nov 04; 25(11):1339-42. PubMed ID: 6890579
    [Abstract] [Full Text] [Related]

  • 16. Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.
    Adams GE, Clarke ED, Flockhart IR, Jacobs RS, Sehmi DS, Stratford IJ, Wardman P, Watts ME, Parrick J, Wallace RG, Smithen CE.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1979 Feb 04; 35(2):133-50. PubMed ID: 312783
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships of 1-substituted 2-nitroimidazoles: effect of partition coefficient and side-chain hydroxyl groups on radiosensitization in vitro.
    Brown DM, Parker E, Brown JM.
    Radiat Res; 1982 Apr 04; 90(1):98-108. PubMed ID: 7199747
    [No Abstract] [Full Text] [Related]

  • 18. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
    Papadopoulou MV, Bloomer WD.
    Anticancer Drugs; 2009 Jul 04; 20(6):493-502. PubMed ID: 19430289
    [Abstract] [Full Text] [Related]

  • 19. Potential Radiosensitizing Agents III: 2-Nitro-4-acetylimidazole analogs.
    Sehgal RK, Agrawal KC.
    J Pharm Sci; 1982 Nov 04; 71(11):1203-6. PubMed ID: 7175708
    [Abstract] [Full Text] [Related]

  • 20. Cellular uptake of misonidazole and analogues with acidic or basic functions.
    Dennis MF, Stratford MR, Wardman P, Watts ME.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun 04; 47(6):629-43. PubMed ID: 3873433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.